Clinical Trial

Evaluating the Influence of Diet-induced Weight Loss on Fat (Adipose) Tissue's Insulin Sensitivity and Testosterone Synthesis in Women With Overweight or Obesity, Insulin Resistance, and Hyperandrogenemia

Study acronym: WAIST
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The investigators will measure plasma concentrations of the hormones insulin and testosterone as well as measures of insulin sensitivity in women with overweight or obesity who have insulin resistance (IR). Women who meet these criteria that also have elevated total or free testosterone will be eligible to participate in the diet intervention. The dietary intervention is designed to produce a 5% reduction in starting body weight to test whether weight loss will acutely lower fasting insulin and testosterone concentrations.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-28.
Trial Details
NCT Number NCT06998238
Lead Sponsor University of Missouri-Columbia
Conditions Overweight and Obesity, Hyperandrogenemia, Insulin Resistance
Enrollment 8 participants
Start Date 2024-01-07
Primary Completion 2024-10-05 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-17